Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase-4 inhibitor, examined in non-obese diabetic mice-Reference-Cited by-同舟云学术

Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase-4 inhibitor, examined in non-obese diabetic mice

Published:2012-05-22 Issue:5 Volume:3 Page:441-448
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:

Author:

Tsuji Takumi,Yoshida Yuya,Fujita Tetsuro,Kohno Takeyuki

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.2040-1124.2012.00218.x/fullpdf

Reference31 articles.

1. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite;Fujita;J Antibiot,1994

2. Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols;Kiuchi;J Med Chem,2000

3. Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model;Tsunemi;Clin Immunol,2010

4. A novel immunomodulator, FTY720, prevents development of experimental autoimmune myasthenia gravis in C57BL/6 mice;Kohno;Biol Pharm Bull,2005

5. Relapse of experimental autoimmune encephalomyelitis after discontinuation of FTY720 (fingolimod) treatment, but not after combination of FTY720 and pathogenic autoantigen;Yoshida;Biol Pharm Bull,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arachidonic acid alleviates autoimmune diabetes in NOD mice;International Immunopharmacology;2024-01

2. 14-3-3ζ constrains insulin secretion by regulating mitochondrial function in pancreatic β-cells;2021-10-17

3. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions;The Lancet;2021-09

4. Long-term inhibition of dipeptidyl-peptidase 4 reduces islet infiltration and downregulates IL-1β and IL-12 in NOD mice;International Immunopharmacology;2020-11

5. The potential application of Cordyceps in metabolic‐related disorders;Phytotherapy Research;2019-10-31